amiodarone has been researched along with metaproterenol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Anselmi, E; Aznar, E; Brugger, AJ; Monfort, R; Morales-Olivas, FJ | 1 |
| Pidrman, V; Pleskot, M; Tilser, P | 1 |
| Bollmann, A; Hilbert, S; Hindricks, G; John, S; Kosiuk, J | 1 |
1 review(s) available for amiodarone and metaproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for amiodarone and metaproterenol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Pharmacodynamic interaction between amiodarone and the beta-sympathomimetics].
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Benzofurans; Drug Interactions; Female; Fenoterol; Metaproterenol; Uterine Contraction | 1978 |
[Combinations of anti-arrhythmia agents and the heart conduction system].
Topics: Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atropine; Drug Therapy, Combination; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Metaproterenol; Middle Aged | 1988 |
Insights from preclinical ultra high-density electroanatomical sinus node mapping.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function, Right; Electrophysiologic Techniques, Cardiac; Epicardial Mapping; Heart Atria; Metaproterenol; Propranolol; Sinoatrial Node; Swine | 2015 |